Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors

Class III β-tubulin (TUBB3) and Topoisomerase-II (topo-II) are considered to be the predictors of therapeutic efficacy and outcome in several types of human neoplasm. However, whether TUBB3 or topo-II may predict the response to combination chemotherapy and prognosis in patients with advanced thymic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Miura, Yosuke, Kaira, Kyoichi, Sakurai, Reiko, Imai, Hisao, Tomizawa, Yoshio, Sunaga, Noriaki, Minato, Koichi, Hisada, Takeshi, Oyama, Tetsunari, Yamada, Masanobu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530002/
https://ncbi.nlm.nih.gov/pubmed/28789453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados